For years, conversations about artificial intelligence in healthcare focused on how technology can support clinicians behind the scenes. But something more fundamental is starting to take shape, and it is unfolding faster than many organizations anticipated.
More often, the first step in a patient’s care journey begins with a question posed to an AI tool. In moments of urgency or uncertainty, people are using AI to interpret symptoms, understand options, and decide what to do next.
That behavior places AI at the front of the care experience. In many cases, AI is influencing decisions that resemble triage, often before a clinician is ever involved. As a result, its influence extends beyond information into decision-making, shaping steps that have historically been guided within clinical workflows. Once guidance informs what someone does next, it becomes part of the care pathway, whether it was designed with that responsibility in mind or not.
Patients aren’t turning to AI to replace clinicians. They’re responding to a system that can be difficult to navigate, especially outside of scheduled care. AI meets them in those moments with immediacy and accessibility, offering direction when they’re unsure how serious a symptom may be or what level of care is appropriate.
That accessibility brings real value. AI can translate complex information into something more usable and help patients revisit guidance after a visit, when questions tend to resurface. At the same time, the underlying models are improving quickly, with more advanced reasoning capabilities emerging in a short period of time.
As AI moves earlier in the care journey and begins to shape decisions more directly, it raises a new set of clinical and operational questions that healthcare leaders need to account for. This is particularly true when AI is embedded within care delivery models.
When capability outpaces clinical governance
Just months ago, the primary concern around AI-driven health guidance was whether models could generate answers that sounded convincing but were incorrect. That concern hasn’t disappeared, but it’s evolved. Recent studies suggest advanced models are improving in structured clinical reasoning tasks, reflecting the pace of progress in a short period of time.
Yet performance alone doesn’t determine how AI functions in real-world care. As these systems become more capable, their influence can expands beyond traditional clinical oversight.
In practice, the risk is less about whether an answer is technically accurate and more about whether it operates within a governed pathway, with clear escalation, oversight, and accountability needed to safeguard patient safety. When AI is embedded within care delivery, those guardrails become essential.
The overlooked moment after guidance
That distinction becomes more important as AI begins to influence what people do next: whether someone decides to seek care, delay it, or manage symptoms on their own.
Even when guidance is sound, it doesn’t always translate into clear or appropriate action. Interpreting information and acting on it are different steps, and the space between them is where risk can build.
What’s often missing is ownership of that next step. In some cases, when someone acts on AI guidance, those decisions may fall outside a clinically governed pathway, without a defined handoff into care or clear accountability for the outcome. In those moments, clinical oversight may no longer be part of the process, even when risk is present.
Rethinking “human in the loop”
Much of the responsible AI discourse frames human oversight as a checkpoint at the end of an interaction. In reality, decisions are often being shaped much earlier.
If AI plays a role in how care begins, then clinical context and accountability need to be embedded from the start. That requires more than generating responses. It requires a model that connects individuals to appropriate next steps, recognizes when escalation is needed, and ensures there’s clear responsibility for what happens next.
Clinical responsibility must remain anchored with licensed providers, supported by systems that guide patients into appropriate care pathways.
Operationalizing this model depends on structure. Clear escalation pathways, integration into records, and visibility into how guidance is used all contribute to a system that can manage clinical risk. Without those elements, guidance exists in parallel to care delivery rather than as part of it.
The goal isn’t to slow care. It’s to ensure that faster access to information is supported by the infrastructure needed to guide decisions safely and maintain accountability across the care journey.
From performance to accountability
As AI capabilities continue to advance, attention is shifting toward how and where these tools are applied. The conversation now centers on where AI fits within the care journey, how it’s governed, and how accountability is defined when it influences decisions.
AI can play a meaningful role in organizing information and helping patients orient themselves quickly. Clinical judgment, risk assessment, and escalation decisions, however, depend on clinical oversight. The value of AI comes from extending that judgment, making it more consistent and accessible, while keeping responsibility clearly within a governed care model.
What ultimately matters is how each interaction connects back to accountable care, and whether there is a clear path forward when decisions carry clinical risk.
A leadership moment
As AI reshapes how patients engage with healthcare, organizations have a choice in how they respond. Some will embed AI within clinically governed models of care, with defined escalation pathways and clear accountability. Others will allow guidance to operate alongside the system, without full visibility into how decisions are carried forward.
The decisions made now will determine how AI is integrated into care delivery and whether expanding access is matched with the clinical responsibility required to support it.
Organizations that establish this foundation early will help shape not only how AI is used, but how care is experienced and managed moving forward.
To learn more about MD Live by Evernorth, visit our website.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
